Cellbxhealth (LON:CLBX) Announces Earnings Results

Cellbxhealth (LON:CLBX) issued its quarterly earnings results on Wednesday. The company reported GBX (0.24) EPS for the quarter, Digital Look Earnings reports.

Cellbxhealth Price Performance

Cellbxhealth stock opened at GBX 1.28 on Friday. Cellbxhealth has a 52 week low of GBX 0.85 and a 52 week high of GBX 2.70. The company has a market cap of £14.51 million and a PE ratio of -0.23.

About Cellbxhealth

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.